The BN™ II System and its nephelometric technology provide uncompromising performance in plasma protein analysis. The menu covers assays to support a variety of clinical indications, such as cardiac risk assessment, kidney diseases, nutritional assessment, and innovative markers such as monoclonal kappa and lambda free light chains, Cystatin C and Carbohydrate-Deficient Transferrin (CDT).
- Ideal for mid- to high-volume plasma protein throughput
- Comprehensive menu from one source: Over 64 assay protocols available for determination of various sample types
- Up to 100 samples onboard
- Antigen-excess security for confidence in results
- Assistance with clinical interpretation through our innovative range of assessment programs available for Protis® Data Management System*